Clinical Trial Update: Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion [NA]

View source ↗

Summary

A completed clinical trial compared Bevacizumab to Ranibizumab for macular edema due to retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Ranibizumab (Lucentis) (ranibizumab)

Snippet

Sponsor: Barnes Retina Institute | Conditions: Retinal Vein Occlusion, Macular Edema | NA | Status: COMPLETED